BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 31129431)

  • 1. Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice.
    Li WK; Wang GF; Wang TM; Li YY; Li YF; Lu XY; Wang YH; Zhang H; Liu P; Wu JS; Ma YM
    Phytomedicine; 2019 Sep; 62():152948. PubMed ID: 31129431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yinchenzhufu decoction protects against alpha-naphthylisothiocyanate-induced acute cholestatic liver injury in mice by ameliorating disordered bile acid homeostasis and inhibiting inflammatory responses.
    Wang GF; Li YY; Shi R; Wang TM; Li YF; Li WK; Zheng M; Fan FB; Zou J; Zan B; Wu JS; Ma YM
    J Ethnopharmacol; 2020 May; 254():112672. PubMed ID: 32084553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters.
    Xue H; Fang S; Zheng M; Wu J; Li H; Zhang M; Li Y; Wang T; Shi R; Ma Y
    J Ethnopharmacol; 2021 Apr; 269():113706. PubMed ID: 33346024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice.
    Wu JS; Li YF; Li YY; Dai Y; Li WK; Zheng M; Shi ZC; Shi R; Wang TM; Ma BL; Liu P; Ma YM
    Front Pharmacol; 2017; 8():938. PubMed ID: 29311939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatoprotective effects of Huangqi decoction (Astragali Radix and Glycyrrhizae Radix et Rhizoma) on cholestatic liver injury in mice: Involvement of alleviating intestinal microbiota dysbiosis.
    Zou J; Li W; Wang G; Fang S; Cai J; Wang T; Zhang H; Liu P; Wu J; Ma Y
    J Ethnopharmacol; 2021 Mar; 267():113544. PubMed ID: 33152436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huangqi decoction alleviates dimethylnitrosamine-induced liver fibrosis: An analysis of bile acids metabolic mechanism.
    Song YN; Zhang GB; Lu YY; Chen QL; Yang L; Wang ZT; Liu P; Su SB
    J Ethnopharmacol; 2016 Aug; 189():148-56. PubMed ID: 27196295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics analysis delineates the therapeutic effects of Huangqi decoction and astragalosides on α-naphthylisothiocyanate (ANIT) -induced cholestasis in rats.
    Qiu J; Yan J; Liu W; Liu X; Lin J; Du Z; Qi L; Liu J; Xie G; Liu P; Wang X
    J Ethnopharmacol; 2021 Mar; 268():113658. PubMed ID: 33307056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragalus saponins protect against extrahepatic and intrahepatic cholestatic liver fibrosis models by activation of farnesoid X receptor.
    Zhang L; Shi J; Shen Q; Fu Y; Qi S; Wu J; Chen J; Zhang H; Mu Y; Chen G; Liu P; Liu W
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116833. PubMed ID: 37400008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network pharmacology-based mechanism prediction and pharmacological validation of Xiaoyan Lidan formula on attenuating alpha-naphthylisothiocyanate induced cholestatic hepatic injury in rats.
    Wang M; Liu F; Yao Y; Zhang Q; Lu Z; Zhang R; Liu C; Lin C; Zhu C
    J Ethnopharmacol; 2021 Apr; 270():113816. PubMed ID: 33444723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying hepatoprotective mechanism and effective components of Yinchenzhufu decoction in chronic cholestatic liver injury using a comprehensive strategy based on metabolomics, molecular biology, pharmacokinetics, and cytology.
    Li Y; Peng X; Wang G; Zan B; Wang Y; Zou J; Tian T; Meng Q; Shi R; Wang T; Wu J; Ma Y
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117060. PubMed ID: 37598769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wedelolactone alleviates cholestatic liver injury by regulating FXR-bile acid-NF-κB/NRF2 axis to reduce bile acid accumulation and its subsequent inflammation and oxidative stress.
    Wang MQ; Zhang KH; Liu FL; Zhou R; Zeng Y; Chen AL; Yu Y; Xia Q; Zhu CC; Lin CZ
    Phytomedicine; 2024 Jan; 122():155124. PubMed ID: 38014837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Proteomics Reveals the Protective Effects of Huangqi Decoction Against Acute Cholestatic Liver Injury by Inhibiting the NF-κB/IL-6/STAT3 Signaling Pathway.
    Wu JS; Liu Q; Fang SH; Liu X; Zheng M; Wang TM; Zhang H; Liu P; Zhou H; Ma YM
    J Proteome Res; 2020 Feb; 19(2):677-687. PubMed ID: 31852184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huang Qi Decoction Prevents BDL-Induced Liver Fibrosis Through Inhibition of Notch Signaling Activation.
    Zhang X; Xu Y; Chen JM; Liu C; Du GL; Zhang H; Chen GF; Jiang SL; Liu CH; Mu YP; Liu P
    Am J Chin Med; 2017; 45(1):85-104. PubMed ID: 28081630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatoprotective effects of Sedum sarmentosum extract and its isolated major constituent through Nrf2 activation and NF-κB inhibition.
    Wang GW; Zhang XL; Wu QH; Jin YB; Ning CT; Wang R; Mao JX; Chen M
    Phytomedicine; 2019 Feb; 53():263-273. PubMed ID: 30668406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis.
    Wang Y; Li Y; Zhang H; Zhu L; Zhong J; Zeng J; Meng C; Wu J; Wang T; Shi R; Yuan W; Jiang J; Liu P; Ma Y
    Phytomedicine; 2021 Apr; 84():153513. PubMed ID: 33647776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANIT-induced intrahepatic cholestasis alters hepatobiliary transporter expression via Nrf2-dependent and independent signaling.
    Tanaka Y; Aleksunes LM; Cui YJ; Klaassen CD
    Toxicol Sci; 2009 Apr; 108(2):247-57. PubMed ID: 19181614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Activation of Retrorsine may Disrupt Bile Acid Homeostasis in Mice through the Nrf2 Pathway.
    Pang X; Tang C; Cao P; Zhou L; Chen X
    Curr Drug Metab; 2021; 22(11):870-881. PubMed ID: 33906588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
    Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
    J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
    J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.